INS and insomnia measurement: Other associated factors include an increased BMI of 1.26, serum triglyceride levels by 1.23 mmol/L, T2D risk by 2.07 times, fasting insulin by 1.14 pmol/L, insomnia rate by 53%, and visceral adipose tissue volume by 51%.